Showing results (211-220 of 227) with videos related to

Sort By:
Pageof 23
Leukemia|July 28, 2022
ASXL1 mutations predict inferior molecular response to nilotinib treatment in chronic myeloid leukemiaLioba Schönfeld, Jenny Rinke, Anna Hinze, et al.
Molecular Pharmaceutics|February 4, 2021
Interaction of Polymers with Enzalutamide Nanodroplets-Impact on Droplet Properties and Induction TimesVenecia R Wilson, Naila A Mugheirbi, Laura I Mosquera-Giraldo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 6, 2017
Reduced CD62L Expression on T Cells and Increased Soluble CD62L Levels Predict Molecular Response to Tyrosine Kinase Inhibitor Therapy in Early Chronic-Phase Chronic Myelogenous LeukemiaSieghart Sopper, Satu Mustjoki, Deborah White, et al.
Journal of Cancer Research and Clinical Oncology|February 21, 2020
Hemophagocytic lymphohistiocytosis in adults: collaborative analysis of 137 cases of a nationwide German registrySebastian Birndt, Thomas Schenk, Babett Heinevetter, et al.
Journal of Cancer Research and Clinical Oncology|April 4, 2019
Results of the European survey on the assessment of deep molecular response in chronic phase CML patients during tyrosine kinase inhibitor therapy (EUREKA registry)Susanne Möbius, Thomas Schenk, Danny Himsel, et al.
Frontiers in Aging Neuroscience|June 19, 2025
Interventions for cognitive frailty: developing a Delphi consensus with multidisciplinary and multisectoral expertsCarol A Holland, Nikolett Dravecz, Susan Broughton, et al.
NPJ Microgravity|April 8, 2026
A study on the stability of ritonavir form III processed in orbit and returned to EarthHaley C Bauser, Pamela A Smith, Stephan D Parent, et al.
World Neurosurgery|January 9, 2013
Subarachnoid Hemorrhage International Trialists data repository (SAHIT)R Loch Macdonald, Michael D Cusimano, Nima Etminan, et al.
Pageof 23